We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Automated Image Analysis Software Reliably Identifies Positive MRSA

By LabMedica International staff writers
Posted on 24 Feb 2016
In a unique-in-its-class digital microbiology study of almost 60,000 samples, new WASPLab software developed for automated colony-scoring of chromegenic media plates provided superior detection of methicillin-resistant Staphylococcus aureus (MRSA).

The groundbreaking results came from an international multicenter study, testing 57,690 samples, where the WASPLab platform software “Chromogenic Detection Module” (CDM) from COPAN Diagnostics, Inc. More...
(Murrieta, CA, USA) detected and segregated positive from negative MRSA samples using chromogenic agar with a sensitivity of 100% and a specificity of 90%–96% (varying by location). The software detected an additional 153 positive MRSA patients that were missed by manual reading.

The study's sample size and level of sensitivity of 100% “makes this study unmatched in the industry," said Norman Sharples, CEO, Copan Diagnostics.

CDM utilizes an algorithm to identify presence of colonies on a plate and distinguish between different colors to group into negative and positive cultures. The study focused on identifying MRSA using chromogenic agar from 3 different manufacturers (BD Diagnostics, bioMeriéux, Bio-Rad Laboratories) that produce growth with different pigmentation colors. The cultures were read automatically by WASPLab CDM and manually by a laboratory professional. The laboratory professionals were blinded to the software's results.

CDM's reading threshold is intentionally set with a high level of prudency designed so it does not miss a positive MRSA culture. In fact, in this large study, CDM never reported any manual positive plates as negative, demonstrating 100% sensitivity. The 90%–96% specificity score varies by location due to the conservative threshold of the CDM settings, which set the limitations low in order to avoid any "false negative" interpretation. Most importantly, the data from this study suggests that the CDM software is somewhat more sensitive than manual reading of plate cultures.

The software’s “capability reduces the hands-on time considerably,” said Dr. Sharples, “CDM is not meant to be used without the technologist, but to provide the technologist with valuable tools that rapidly pre-screen cultures, detect the presence of specific organisms of interest or known pathogens, then segregate cultures into positive and negative groups that enable faster turnaround times and actionable results within the therapeutic window."

The results of the data show that the WASPLab CDM can be used to accurately sort regardless of the chromogenic substrate. Its application for MRSA is only the first step in a series of algorithms developed by COPAN and available to WASPLab users to further the relevance and speed of laboratory results.

"Clinical microbiology relies heavily on the reading and interpretational skills of the technologist and microbiologist. In a time of diminishing resources and increasing work volumes the advancement in these imaging algorithms supports the value of digital microbiology and full laboratory automation for the continued output of quality results and improved patient care," concluded Dr. Sharples.

The study, by Faron ML et al., was published online ahead of print December 30, 2015, in the Journal of Clinical Microbiology.

Related Links:

COPAN Group



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.